[LINC00475在多发性骨髓瘤中的表达和临床意义]
Ling Lu1, Dan Guo1, Le-Min Hong1
1Department of Hematology, The Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Zhongguo shi yan xue ye xue za zhi
|June 27, 2024
概括
多发性骨髓瘤 (MM) 患者的血清LINC00475显著升高,有助于诊断. 它的表达与关键预后指标相关,如β-2微型血球蛋白和ISS阶段.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血液性恶性瘤,其特征是血细胞的不受控制的增殖.
- 准确的诊断和预后生物标志物对于有效的MM管理至关重要.
研究的目的:
- 为了研究MM患者血清中长非编码RNALINC00475的表达水平.
- 评估血清LINC00475在MM中的临床意义和诊断价值.
主要方法:
- 来自108名MM患者和5个MM细胞系的血清样本使用实时光定量PCR分析了LINC00475表达.
- 采用接收器操作特征 (ROC) 曲线分析来评估LINC00475.5的诊断准确性.
- 在LINC00475水平和患者临床特征之间进行了相关性分析.
主要成果:
- 与对照组相比,LINC00475表达在MM患者和细胞系的血清中显著上调 (P < 0.05).
- ROC分析表明,MM中的LINC00475具有良好的诊断价值,曲线下的面积 (AUC) 为0.924,灵敏度为83.3%,特异性为91.7%.
- 在MM患者中,升高的LINC00475水平与较高的β-2微型血球蛋白和cystatin C,较低的白蛋白和高级国际分期系统 (ISS) 阶段 (II和III) 相关 (P <0.05).
结论:
- 血清LINC00475作为一个有价值的生物标志物,用于区分MM患者和健康个体.
- 在多发性骨髓瘤中,LINC00475的表达与已确定的预后指标有显著的相关性,包括β-2微型血球蛋白,白蛋白和ISS阶段.
关键词:
多发性髓瘤;多发性髓瘤;更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


